NIAID launches program to apply immunology to biodefense

Bioterrorism

Sep 17, 2003 (CIDRAP News) – The National Institute of Allergy and Infectious Disease (NIAID) today announced a new $85 million program to study the human immune response to diseases of bioterrorism and develop vaccines, drugs, and other countermeasures.

The NIAID named five "Cooperative Centers for Translational Research on Human Immunology and Biodefense": Baylor Research Institute, Dallas; Dana-Farber Cancer Institute, Boston; Emory University School of Medicine, Atlanta; Stanford University School of Medicine, Stanford, Calif.; and the University of Massachusetts Medical School, Worcester. The agency said it will provide about $85 million over 4 1/2 years for the centers.

"A particular emphasis of these cooperative centers will be moving new findings about immune system function out of the lab and into clinical trials," NIAID Director Anthony S. Fauci, MD, said in a news release. "The flexibility of the program will allow research projects to be redirected quickly as new information is generated in the lab and the clinic."

Investigators working in the new program will form a research network with a focus on the human immune system, the NIAID said. The agency noted that it is much harder to study immunity in humans than in animals because, among other reasons, humans can’t be deliberately exposed to pathogens.

One aim of the new program is to develop technologies to help overcome the obstacles to studying immune responses, Helen Quill, PhD, of NIAID’s Division of Allergy, Immunology and Transplantation (DAIT), said in the release. For example, researchers hope to develop new ways to get information from single immune cells, so that very small tissue and blood samples can be tested. Quill said plans also call for developing new imaging techniques to allow noninvasive, real-time views of the body as it reacts to a vaccine or infection.

The new centers will strongly emphasize information sharing, Daniel Rotrosen, MD, director of the DAIT, stated in the news release. "Ultimately, we hope to characterize human immune responses to disease-causing organisms and develop therapies that strengthen these responses, whether the organisms are deliberately released or arise naturally in the environment," Rotrosen said. "The cooperative centers will encourage the kind of synergy needed to meet that goal."

See also:

NIAID news release
http://www.niaid.nih.gov/news/newsreleases/2003/Pages/researchaward.aspx

This week's top reads

  1. Vietnam reports H5N1 avian flu case with encephalitis

    Tests on respiratory samples were negative, but results were positive for the cerebrospinal fluid sample.

    Lisa Schnirring
    ICU monitors

  2. Studies detail high rates of long COVID among healthcare, dental workers

    The most common symptom reported by healthcare workers was fatigue.

    Stephanie Soucheray
    health worker in mask

  3. CIDRAP launches Vaccine Integrity Project to help safeguard US vaccine use

    The steering committee will make recommendations on how non-governmental groups can help ensure that vaccine use is evidence-based.

    Mary Van Beusekom
    MMR vaccine vial on table

  4. Top virologists urge world leaders to act on rising avian flu threat

    Global Virus Network scientists highlight the need for robust surveillance, enhanced biosecurity, and readiness for potential human-to-human viral transmission.

    Mary Van Beusekom

  5. Tick-borne meat allergy may be related to urbanization in mid-Atlantic US

    The study identified open-space development and low population density as risk factors for Alpha-gal syndrome. 

    Mary Van Beusekom
    Lone star tick

  6. US measles cases climb higher, approach 900

    Thirty states have cases, and 83% of infections are part of outbreaks, the largest centered  in West Texas.

    Lisa Schnirring
    young boy with measles

  7. USDA withdraws proposal to reduce Salmonella in poultry

    The Biden-era rule would have prevented the sale of raw chicken or turkey with certain levels or strains of Salmonella.

    Chris Dall
    Raw poultry in processing plant

  8. New agreement geared toward universal avian flu vaccine

    The mRNA vaccine targets all major clades of the H5 avian flu subtype.

    Stephanie Soucheray

  9. Quick takes: Mpox outbreak in Malawi, more H5N1 in Idaho and California dairy cows

    The cases in Malawi bring the number of African countries affected by mpox to 23.

    Lisa Schnirring

  10. Measles cases in Europe, the Americas skyrocket

    Almost 90% of the European cases were reported in Romania.

    Stephanie Soucheray
    measles vax

Our underwriters